Hot Pursuit     28-Oct-21
Alembic Pharmaceuticals Ltd continues to fall
Alembic Pharmaceuticals Ltd is quoting at Rs 750.8, down 0.79% on the day as on 13:24 IST on the NSE. The stock tumbled 22.61% in last one year as compared to a 54.42% rally in NIFTY and a 23.73% spurt in the Nifty Pharma index.

Alembic Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quoting at Rs 750.8, down 0.79% on the day as on 13:24 IST on the NSE. The benchmark NIFTY is down around 1.03% on the day, quoting at 18022.6. The Sensex is at 60545.67, down 0.98%.Alembic Pharmaceuticals Ltd has eased around 5.53% in last one month.Meanwhile, Nifty Pharma index of which Alembic Pharmaceuticals Ltd is a constituent, has eased around 3.57% in last one month and is currently quoting at 14094.25, down 1.45% on the day. The volume in the stock stood at 69473 shares today, compared to the daily average of 4.61 lakh shares in last one month.

The benchmark October futures contract for the stock is quoting at Rs 751.55, down 0.78% on the day. Alembic Pharmaceuticals Ltd tumbled 22.61% in last one year as compared to a 54.42% rally in NIFTY and a 23.73% spurt in the Nifty Pharma index.

The PE of the stock is 14.18 based on TTM earnings ending June 21.

Previous News
  Alembic Pharma suspends Sikkim facility operations due to floods
 ( Hot Pursuit - 04-Oct-23   14:39 )
  Alembic Pharmaceuticals announces board meeting date
 ( Corporate News - 19-Jan-24   14:13 )
  Alembic Pharmaceuticals receives USFDA approval for Cyclophosphamide Capsules
 ( Corporate News - 14-Nov-22   09:11 )
  Alembic Pharmaceuticals resumes operations at Namthang unit
 ( Corporate News - 01-Feb-24   20:15 )
  Alembic Pharmaceuticals fixes record date for interim dividend
 ( Market Beat - Reports 27-Jul-22   14:22 )
  Alembic Pharma subsidiary receives final approval for lidocaine cream
 ( Hot Pursuit - 12-Apr-22   10:57 )
  Alembic Pharma gets USFDA nod for Doxycycline Capsules
 ( Hot Pursuit - 28-Jun-24   12:20 )
  Alembic Pharmaceuticals Ltd gains for third straight session
 ( Hot Pursuit - 27-Jun-22   13:05 )
  Aleor Dermaceuticals receives USFDA approval for Lidocaine 2.5% and Prilocaine 2.5% Cream
 ( Corporate News - 12-Apr-22   10:20 )
  Alembic Pharma Q3 PAT slips 29% YoY; R&D spend at Rs 157 crore
 ( Hot Pursuit - 02-Feb-23   10:41 )
  Alembic Pharmaceuticals receives USFDA approval for Doxycycline Capsules
 ( Corporate News - 28-Jun-24   13:38 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top